Regarding p2, I got the distinct impression from the cc that in two weeks from now, NP will submit the data to the FDA whether the 75 patient mark in enrollment is reached or not. So FDA decision mid to late June is very likely imho. As to p2-3, only 13 more patients needed until 50 enrolled, at which point NP is likely to submit the data to FDA; therefore I believe the same timeframe for p2 will apply to p2-3 imho.